Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
Sep. 30, 2026 |
Aug. 24, 2026 |
Aug. 21, 2026 |
Aug. 20, 2026 |
Jul. 31, 2026 |
Jun. 29, 2026 |
Jun. 26, 2026 |
Jun. 05, 2026 |
Jun. 02, 2026 |
May 20, 2026 |
Apr. 30, 2026 |
Apr. 02, 2026 |
Oct. 24, 2025 |
Sep. 30, 2025 |
Sep. 05, 2025 |
Jul. 02, 2025 |
Jun. 03, 2024 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Jul. 22, 2026 |
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
500,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
500,000,000
|
|
500,000,000
|
|
| Preferred stock, shares authorized |
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
5,000,000
|
|
5,000,000
|
|
| Common stock, shares issued |
1,318,521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,318,521
|
|
1,318,521
|
|
459,286
|
|
| Common stock, shares outstanding |
1,318,521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,318,521
|
|
1,318,521
|
|
459,286
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Forgivness of accrued compensation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 875,315
|
|
|
|
| Equity consideration amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 889,478
|
|
889,478
|
|
|
|
| Cash obligation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,058,546
|
|
|
|
| Sale of shares of common stock |
|
|
|
|
|
|
213,333
|
|
|
|
|
|
|
|
|
|
|
13,466
|
|
|
|
267
|
|
| Sale of Stock, Price Per Share |
$ 17.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17.51
|
|
$ 17.51
|
|
|
|
| Aggregate proceeds share issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 87,055
|
|
|
|
$ 22,251
|
|
| Proceeds before offering expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3,719,998
|
|
|
|
| Share based compensation arrangement description |
|
|
|
|
|
|
|
the Company entered into Amendment No. 3 to Alison Silva’s employment agreement, appointing Ms. Silva as Chief Operating
Officer and President and increasing her base salary to $340,200 from $315,000. In connection with the amendment, on June 2, 2026, the
Board approved a one-time option grant to Ms. Silva to purchase up to 8,000 shares of common stock under the 2025 Equity Incentive Plan,
vesting over three years commencing September 2, 2026 in equal quarterly installments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options issued |
192,765
|
|
|
|
|
|
|
|
2,666
|
|
|
|
|
|
|
|
|
192,765
|
|
192,765
|
|
|
|
| Vested performance description |
|
|
|
|
|
On
June 29, 2026, in connection with his appointment to the Board of Directors, the Company granted Tomas J. Philipson, Ph.D. options to
purchase an aggregate of 7,152 shares of common stock under the 2025 Equity Incentive Plan. The grants consisted of (i) an option to
purchase 1,200 shares in connection with his appointment and (ii) an option to purchase 5,952 shares in lieu of the annual cash retainer
and committee fees otherwise payable for his service on the Board and its committees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense related to shares issued for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 46,750
|
66,000
|
|
|
| Issued of aggregate fair value shares |
|
|
|
|
|
|
|
|
|
|
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of restricted shares issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Compensation expense for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 389,707
|
$ 389,707
|
|
|
|
|
| Share price |
$ 62.33
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 62.33
|
|
$ 62.33
|
|
$ 77.56
|
|
| Vested, term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 years 7 months 6 days
|
|
5 years 4 months 24 days
|
|
| Stock options issued |
192,765
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
192,765
|
|
192,765
|
|
156,331
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,543,863
|
|
|
|
| Stock-based compensation expense related to equity awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 551,874
|
792,725
|
$ 1,497,113
|
$ 1,676,667
|
|
|
| Percentage of restricted stock units vested on grant date |
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares outstanding |
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,333
|
|
1,333
|
|
|
|
| Vested shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
583
|
|
|
|
| Unvested shares |
750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
750
|
|
750
|
|
|
|
| Unrecognized stock-based compensation |
$ 1,592,908
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,592,908
|
|
$ 1,592,908
|
|
|
|
| Recognized over a period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 3 months 18 days
|
|
|
|
| Two Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock granted |
|
|
|
|
|
|
|
|
|
|
|
2,666
|
|
|
4,996
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
$ 27.75
|
|
|
$ 92.25
|
|
|
|
|
|
|
|
|
| Fair value of grant date |
|
|
|
|
|
|
|
|
|
|
|
$ 73,982
|
|
|
$ 340,900
|
|
|
|
|
|
|
|
|
| Vested, term |
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options vest percentage |
|
|
|
|
|
|
|
|
|
|
|
25.00%
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
| Option vested |
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
3,747
|
|
|
|
|
|
|
|
|
| Office Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock granted |
|
|
|
|
|
|
|
|
46,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
$ 20.85
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of grant date |
|
|
|
|
|
|
|
|
$ 973,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested, term |
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options vest percentage |
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock granted |
|
|
|
|
|
7,152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
$ 21.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of grant date |
|
|
|
|
|
$ 150,192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested, term |
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Andrew J. Cutler [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock granted |
|
|
|
|
6,296
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
$ 6.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Board of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 89.25
|
|
|
|
|
|
|
|
| Stock options issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,765
|
|
|
|
|
|
|
|
| Vesting period description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The stock options have a 10-year term and vest in equal installments over a three (3) year period beginning on
the grant date of July 2, 2025, subject to the officers’ continued employment at the time of vesting.
|
|
|
|
|
|
|
|
| One Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
1,465
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 92.25
|
|
|
|
|
|
|
|
|
| Fair value of grant date |
$ 100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vested performance description |
(a) 15% per Ambassador (maximum
of three) referred by consultant and subsequently engaged by the Company, (b) 20% if consultant is instrumental in arranging a distribution
arrangement not previously pursued by the Company, on terms acceptable to the Company, (c) 20% when such Distribution Contract achieves
$1 million in annual sales and (d) 15% when the consultant arranges the first Celebrity Golf Tournament featuring Nugevia on terms and
conditions acceptable to the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2025 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options issued |
|
|
|
|
|
|
|
|
28,820
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Note One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
290,874
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,218,365
|
|
|
|
| 2025 Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock upon conversion of convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,519
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity consideration amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
|
|
$ 13
|
|
|
|
| Stock options issued |
|
|
|
|
|
|
|
|
1,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
667
|
1,376
|
|
|
| Stock-based compensation expense related to shares issued for services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued of aggregate fair value shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,680
|
|
|
|
| Number of restricted shares issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2
|
|
|
|
| Stock-based compensation expense related to equity awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock purchase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500
|
|
|
|
|
|
|
| Aggregate proceeds share issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
| Issued of aggregate fair value shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,500
|
|
|
|
|
|
|
| Number of restricted shares issued, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,638,375
|
|
|
|
|
|
|
| Share purchase price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 99.75
|
|
|
|
|
|
|
| Common Stock [Member] | IPO [Member] | Entity Three [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued of aggregate fair value shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,500
|
|
|
|
|
|
|
| Pharm Ala License Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of stock purchase |
|
|
|
132,867
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity consideration amount |
|
|
|
$ 889,478
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remaining share issuance |
|
|
|
181,529
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash obligation |
|
|
|
$ 1,058,546
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of shares of common stock |
|
|
307,692
|
|
|
|
|
|
|
95,238
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share |
|
|
$ 6.50
|
|
|
|
|
|
|
$ 21.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate proceeds share issuance |
|
$ 2,000,000.0
|
|
|
|
|
|
|
|
$ 2,000,000.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent fees |
|
|
$ 140,000
|
|
|
|
|
|
|
140,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds before offering expenses |
|
|
$ 1,860,000
|
|
|
|
|
|
|
$ 1,860,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Standby Equity Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,100,000
|
|
| Standby Equity Purchase Agreement [Member] | Convertible Note One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
292,393
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,218,006
|
|
|
|
| Standby Equity Purchase Agreement [Member] | 2025 Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock upon conversion of convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,519
|
|
|
|
| Standby Equity Purchase Agreement [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate proceeds share issuance |
|
|
|
|
|
|
|
|
|
|
|
|
$ 20,000,000.0
|
|
|
|
|
|
|
|
|
|
|
| 2025 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares available for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000
|